Berzofsky, Jay A.
National Institutes of Health · National Cancer Institute · Center for Cancer Research
3 papers on CoChatORCID 0000-0002-0342-3194
Most cited papers
- Verified
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science
Gut microbiota and healthCholangiocarcinoma and Gallbladder Cancer Studies
Cited by 1,508
- Verified
Phase I study of GC1008 (fresolimumab): a human anti‐transforming growth factor‐beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma
Morris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE
TGF-β signaling in diseasesCancer Immunotherapy and Biomarkers
Cited by 487
- Verified
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
Lacouture, M. E., Morris, J. C., Lawrence, D. P., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Berzofsky, J. A., Hsu, F. J., & Guitart, J. (2015) · Cancer Immunology, Immunotherapy
Nonmelanoma Skin Cancer StudiesChemotherapy-related skin toxicity
Cited by 145
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free